Throughout 50 years of cancer research at MIT, our focus has been supporting the people, ideas, and technologies that can change the game in the fight against cancer.
Gifts that drive impact
From every type of donor, at every level of giving, philanthropy fuels the Koch Institute’s high impact cancer research. 2024 marks fifty years of MIT's cancer research program, which began with the opening of the MIT Center for Cancer Research in 1974. As we embark on our next half century, we remain fundamentally committed to the exceptional people, transformative research approaches, and educational missions that define who we are. Supporting these priorities—people, research, and education—takes all of us, together, giving in the ways that feel right for each of us.
Flexibility is essential
Unrestricted support is vital to the Koch Institute's ability to freely innovate and adapt. Your generosity allows us to follow the science and channel support to the initiatives that need it most.
Koch Institute Director's Discretionary Endowed Fund (3199922)
Increasing annual income from this unrestricted endowment enables the Koch Institute to plan strategically and invest where needed—in people, technologies, and research—to stay at the forefront of cancer research. Give now
Koch Institute Director's Fund (2982900)
Your gift provides unrestricted support for the Koch Institute, and will be applied where it is most needed to help us respond to opportunities and challenges as they arise. Give now
